Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study

Abstract Background Human T-cell Leukemia Virus type-1 (HTLV-1) is a retrovirus that causes two diseases including Adult T-cell Leukemia/Lymphoma (ATLL cancer) and HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP, a neurodegenerative disease) after a long latency period as an asymp...

Full description

Bibliographic Details
Main Authors: Mohadeseh Zarei Ghobadi, Rahman Emamzadeh, Majid Teymoori-Rad, Sayed-Hamidreza Mozhgani
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Virology Journal
Subjects:
Online Access:https://doi.org/10.1186/s12985-021-01643-8
_version_ 1818719949568344064
author Mohadeseh Zarei Ghobadi
Rahman Emamzadeh
Majid Teymoori-Rad
Sayed-Hamidreza Mozhgani
author_facet Mohadeseh Zarei Ghobadi
Rahman Emamzadeh
Majid Teymoori-Rad
Sayed-Hamidreza Mozhgani
author_sort Mohadeseh Zarei Ghobadi
collection DOAJ
description Abstract Background Human T-cell Leukemia Virus type-1 (HTLV-1) is a retrovirus that causes two diseases including Adult T-cell Leukemia/Lymphoma (ATLL cancer) and HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP, a neurodegenerative disease) after a long latency period as an asymptomatic carrier (AC). There are no obvious explanations about how each of the mentioned diseases develops in the AC carriers. Finding the discriminative molecular factors and pathways may clarify the destiny of the infection. Methods To shed light on the involved molecular players and activated pathways in each state, differentially co-expressed modules (DiffCoEx) algorithm was employed to identify the highly correlated genes which were co-expressed differently between normal and ACs, ACs and ATLL, as well as ACs and HAM/TSP samples. Through differential pathway analysis, the dysregulated pathways and the specific disease-genes-pathways were figured out. Moreover, the common genes between the member of DiffCoEx and differentially expressed genes were found and the specific genes in ATLL and HAM/TSP were introduced as possible biomarkers. Results The dysregulated genes in the ATLL were mostly enriched in immune and cancer-related pathways while the ones in the HAM/TSP were enriched in immune, inflammation, and neurological pathways. The differential pathway analysis clarified the differences between the gene players in the common activated pathways. Eventually, the final analysis revealed the involvement of specific dysregulated genes including KIRREL2, RAB36, and KANK1 in HAM/TSP as well as LTB4R2, HCN4, FZD9, GRIK5, CREB3L4, TACR2, FRMD1, LHB, FGF3, TEAD3, GRIN2D, GNRH2, PRLH, GPR156, and CRHR2 in ATLL. Conclusion The identified potential prognostic biomarkers and therapeutic targets are proposed as the most important platers in developing ATLL or HAM/TSP. Moreover, the proposed signaling network clarifies the differences between the functional players in the activated pathways in ACs, ATLL, and HAM/TSP.
first_indexed 2024-12-17T20:15:04Z
format Article
id doaj.art-e640f20eef75454b9639b13f32acf781
institution Directory Open Access Journal
issn 1743-422X
language English
last_indexed 2024-12-17T20:15:04Z
publishDate 2021-08-01
publisher BMC
record_format Article
series Virology Journal
spelling doaj.art-e640f20eef75454b9639b13f32acf7812022-12-21T21:34:08ZengBMCVirology Journal1743-422X2021-08-0118111210.1186/s12985-021-01643-8Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology studyMohadeseh Zarei Ghobadi0Rahman Emamzadeh1Majid Teymoori-Rad2Sayed-Hamidreza Mozhgani3Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of IsfahanDepartment of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of IsfahanDepartment of Virology, School of Public Health, Tehran University of Medical SciencesDepartment of Microbiology, School of Medicine, Alborz University of Medical SciencesAbstract Background Human T-cell Leukemia Virus type-1 (HTLV-1) is a retrovirus that causes two diseases including Adult T-cell Leukemia/Lymphoma (ATLL cancer) and HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP, a neurodegenerative disease) after a long latency period as an asymptomatic carrier (AC). There are no obvious explanations about how each of the mentioned diseases develops in the AC carriers. Finding the discriminative molecular factors and pathways may clarify the destiny of the infection. Methods To shed light on the involved molecular players and activated pathways in each state, differentially co-expressed modules (DiffCoEx) algorithm was employed to identify the highly correlated genes which were co-expressed differently between normal and ACs, ACs and ATLL, as well as ACs and HAM/TSP samples. Through differential pathway analysis, the dysregulated pathways and the specific disease-genes-pathways were figured out. Moreover, the common genes between the member of DiffCoEx and differentially expressed genes were found and the specific genes in ATLL and HAM/TSP were introduced as possible biomarkers. Results The dysregulated genes in the ATLL were mostly enriched in immune and cancer-related pathways while the ones in the HAM/TSP were enriched in immune, inflammation, and neurological pathways. The differential pathway analysis clarified the differences between the gene players in the common activated pathways. Eventually, the final analysis revealed the involvement of specific dysregulated genes including KIRREL2, RAB36, and KANK1 in HAM/TSP as well as LTB4R2, HCN4, FZD9, GRIK5, CREB3L4, TACR2, FRMD1, LHB, FGF3, TEAD3, GRIN2D, GNRH2, PRLH, GPR156, and CRHR2 in ATLL. Conclusion The identified potential prognostic biomarkers and therapeutic targets are proposed as the most important platers in developing ATLL or HAM/TSP. Moreover, the proposed signaling network clarifies the differences between the functional players in the activated pathways in ACs, ATLL, and HAM/TSP.https://doi.org/10.1186/s12985-021-01643-8HTLV-1ACsATLLHAM/TSPDifferentially co-expressed modulesPathogenesis
spellingShingle Mohadeseh Zarei Ghobadi
Rahman Emamzadeh
Majid Teymoori-Rad
Sayed-Hamidreza Mozhgani
Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study
Virology Journal
HTLV-1
ACs
ATLL
HAM/TSP
Differentially co-expressed modules
Pathogenesis
title Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study
title_full Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study
title_fullStr Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study
title_full_unstemmed Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study
title_short Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study
title_sort decoding pathogenesis factors involved in the progression of atll or ham tsp after infection by htlv 1 through a systems virology study
topic HTLV-1
ACs
ATLL
HAM/TSP
Differentially co-expressed modules
Pathogenesis
url https://doi.org/10.1186/s12985-021-01643-8
work_keys_str_mv AT mohadesehzareighobadi decodingpathogenesisfactorsinvolvedintheprogressionofatllorhamtspafterinfectionbyhtlv1throughasystemsvirologystudy
AT rahmanemamzadeh decodingpathogenesisfactorsinvolvedintheprogressionofatllorhamtspafterinfectionbyhtlv1throughasystemsvirologystudy
AT majidteymoorirad decodingpathogenesisfactorsinvolvedintheprogressionofatllorhamtspafterinfectionbyhtlv1throughasystemsvirologystudy
AT sayedhamidrezamozhgani decodingpathogenesisfactorsinvolvedintheprogressionofatllorhamtspafterinfectionbyhtlv1throughasystemsvirologystudy